Children's Hospital of Philadelphia researchers discovered a novel immune-based biomarker for early detection of high-grade ovarian cancer up to 4 years earlier than conventional methods.
Children's Hospital of Philadelphia researchers discovered a novel immune-based biomarker that could detect high-grade ovarian cancer (HGOC) up to 4 years earlier than conventional methods. HGOC is the fifth-leading cause of cancer-related death among women, and early detection is crucial for successful treatment. This breakthrough could significantly improve survival rates and treatment options for affected women.
June 14, 2024
3 Articles